Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avenir Entreprises was a prominent French private equity and venture capital firm that specialized in providing growth capital and buyout financing to small and medium-sized enterprises (SMEs). Originally established as a joint subsidiary of Caisse des Dépôts (CDC) and OSEO, the firm played a significant role in the French innovation ecosystem, particularly within the life sciences, technology, and industrial sectors. In 2013, Avenir Entreprises was integrated into Bpifrance, the French public investment bank, as part of a consolidation of state-owned investment entities. During its tenure, it was a frequent lead or co-investor in numerous early-to-mid stage biotechnology and healthcare companies across France, supporting their clinical development and commercial expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avenir Entreprises.